JPMorgan U.S. Value Factor ETF US Value Factor Fund (JVAL)
| Assets | $510.55M |
| Expense Ratio | 0.12% |
| PE Ratio | 16.42 |
| Shares Out | 12.60M |
| Dividend (ttm) | $1.00 |
| Dividend Yield | 2.43% |
| Ex-Dividend Date | Mar 25, 2025 |
| Payout Ratio | 39.90% |
| 1-Year Return | +1.20% |
| Volume | 52,379 |
| Open | 41.15 |
| Previous Close | 41.01 |
| Day's Range | 40.92 - 41.17 |
| 52-Week Low | 35.62 |
| 52-Week High | 46.02 |
| Beta | 0.99 |
| Holdings | 382 |
| Inception Date | Nov 8, 2017 |
About JVAL
Fund Home PageThe JPMorgan U.S. Value Factor ETF US Value Factor Fund (JVAL) is an exchange-traded fund that is based on the JP Morgan US Value Factor index. The fund tracks an index of large-cap US equities that are selected and weighted by four relative valuation factors: book yield, earnings yield, dividend yield and cash flow yield. JVAL was launched on Nov 8, 2017 and is issued by JPMorgan Chase.
Top 10 Holdings
14.96% of assets| Name | Symbol | Weight |
|---|---|---|
| Microsoft Corporation | MSFT | 2.22% |
| Meta Platforms, Inc. | META | 2.00% |
| Alphabet Inc. | GOOGL | 1.86% |
| Apple Inc. | AAPL | 1.73% |
| Broadcom Inc. | AVGO | 1.70% |
| Johnson & Johnson | JNJ | 1.37% |
| Salesforce, Inc. | CRM | 1.13% |
| Oracle Corporation | ORCL | 1.06% |
| International Business Machines Corporation | IBM | 1.04% |
| UnitedHealth Group Incorporated | UNH | 0.85% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 25, 2025 | $0.18387 | Mar 27, 2025 |
| Dec 24, 2024 | $0.29819 | Dec 27, 2024 |
| Sep 24, 2024 | $0.26563 | Sep 26, 2024 |
| Jun 25, 2024 | $0.24882 | Jun 27, 2024 |
| Mar 19, 2024 | $0.14351 | Mar 22, 2024 |
| Dec 19, 2023 | $0.32869 | Dec 22, 2023 |
News
JVAL: Small Growth Exposure, Underperformance As A Consequence
JVAL offers exposure to inexpensive U.S. equities, mostly from mega- and large-cap echelons, while maintaining sector proportions similar to those of the Russell 1000. JVAL is sporting a healthy earni...
JVAL: A Smart Approach To Value
JPMorgan U.S. Value Factor ETF has a smarter strategy than most passive value funds: stock valuation is assessed relative to sector peers.
JVAL: A Healthy Mix Of Inexpensiveness And Profitability, Worth Shortlisting
JVAL is a passively managed fund with a focus on inexpensive players, mostly selected from the Russell 1000 index. Its past performance was mixed as it beat IWD, yet it was unable to keep pace with th...
Reopening trades resurface. Ways to play the move using ETFs
Bryon Lake, head of Americas ETF client at J.P. Morgan Asset Management, and Todd Rosenbluth, senior director of ETF and mutual fund research at CFRA, break down how to play resurgent reopening trades...
ETF Edge: Questions abound about consumer resiliency
Leslie Picker joins the Halftime Report with Bryon Lake, head of Americas ETF client at J.P. Morgan Asset Management, and Todd Rosenbluth, head of ETF & mutual fund research at CFRA, to discuss consum...